Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.70727 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.69896 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.4558 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.67723 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.68142 | 32 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.69797 | 27 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.69685 | 29 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.6857 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.68698 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.75153 | 34 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.68679 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.684 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.0141 | 43 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.69461 | 31 |